Primoris Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.63M Sell
10,764
-104
-1% -$24.2K 1.84% 18
2025
Q4
$2.25M Hold
10,868
1.35% 25
2025
Q3
$2.02M Sell
10,868
-750
-6% -$128K 1.28% 25
2025
Q2
$1.77M Hold
11,618
1.21% 29
2025
Q1
$1.93M Sell
11,618
-541
-4% -$84.6K 1.49% 24
2024
Q4
$1.76M Sell
12,159
-676
-5% -$105K 1.34% 25
2024
Q3
$2.08M Sell
12,835
-200
-2% -$31.9K 1.51% 20
2024
Q2
$1.91M Buy
13,035
+76
+0.6% +$11.3K 1.52% 20
2024
Q1
$2.05M Sell
12,959
-993
-7% -$158K 1.64% 21
2023
Q4
$2.19M Buy
13,952
+160
+1% +$24.5K 2.07% 16
2023
Q3
$2.15M Sell
13,792
-47
-0.3% -$7.75K 2.6% 12
2023
Q2
$2.29M Buy
13,839
+11
+0.1% +$1.77K 2.51% 14
2023
Q1
$2.14M Sell
13,828
-9,982
-42% -$1.61M 2.64% 14
2022
Q4
$4.21M Buy
23,810
+4,298
+22% +$742K 6.48% 3
2022
Q3
$3.19M Sell
19,512
-466
-2% -$78.9K 5.68% 5
2022
Q2
$3.56M Buy
19,978
+466
+2% +$83K 5.11% 3
2022
Q1
$3.46M Hold
19,512
3.23% 10
2021
Q4
$3.34M Buy
+19,512
New +$3.19M 2.69% 13

Other funds holding JNJ

Primoris Wealth Advisors's JNJ Position: Q1 2026 in Review

Primoris Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 0.96% in Q1 2026, selling an estimated $24.2K and leaving 10,764 shares worth $2.63M. The position accounts for 1.84% of the portfolio, ranked #18.

Primoris Wealth Advisors first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.21M in Q4 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Primoris Wealth Advisors held 10,764 shares of Johnson & Johnson worth $2.63M as of Q1 2026.
  • Primoris Wealth Advisors sold 104 Johnson & Johnson shares in Q1 2026, an estimated $24.2K.
  • Johnson & Johnson made up 1.84% of Primoris Wealth Advisors's portfolio in Q1 2026, its #18 holding.
  • Primoris Wealth Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • Primoris Wealth Advisors's Johnson & Johnson position peaked at $4.21M in Q4 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Primoris Wealth Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.